Brain imaging studies of cocaine abuse: Implications for medication development

Critical Reviews in Neurobiology

Volumn 13, Issue 3, 1999, Pages 227-242

  London, Edythe D ^a   Bonson, Katherine R ^a   Ernst, Monique ^a   Grant, Steven ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cocaine; Drug abuse; Magnetic resonance imaging; Positron emission tomography; Treatment

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OPIATE RECEPTOR;

ABSTINENCE; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN MAPPING; BRAIN METABOLISM; COCAINE DEPENDENCE; COGNITION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG WITHDRAWAL; EMOTION; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TIME;

EID: 0033496193     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v13.i3.10     Document Type: Article

References (74)

1. U.S. Department of Health and Human Services, National Household Survey on Drug Abuse: Population Estimates 1995, Rockville, DHHS Publication No. (SMA) 96-3095, 1996.
2. Johnston, L. D., Bachman, J. G., and O'Malley, P. M., Monitoring the Future, Ann Arbor, Institute for Social Research, The University of Michigan, 1997.
3. Johnston, L. D., Bachman, J. G., and O'Malley, P. M., Monitoring the Future, Ann Arbor, Institute for Social Research, The University of Michigan, 1986.
4. Warach, S., Mapping brain pathophysiology and higher cortical function with magnetic resonance imaging, The Neuroscientist, 1, 221-235, 1995.
5. Cohen, M. S. and Bookheimer, S. Y., Localization of brain function using magnetic resonance imaging, Trends Neurosci., 17, 268-277, 1994.
6. London, E. D., Cascella, N. G., Wong, D. F. et al., Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose, Arch. Gen. Psychiatry, 47, 567-574, 1990.
7. London, E. D., Grant, S. J., Morgan, M. J., and Zukin, S. R., Neurobiology of drug abuse, in Neuropsychiatry, Fogel, B. S., Schiffer, R. B., and Rao, S. M., Eds., William & Wilkins, Baltimore, MD, 1996, 635-678.
8. London, E. D., Broussolle, E. P., Links, J. M. et al., Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose, Arch. Gen. Psychiatry, 47, 73-81, 1990.
9. Walsh, S. L., Gilson, S. F., Jasinski, D. R. et al., Buprenorphine reduces cerebral glucose metabolism in polydrug abusers, Neuropsychopharmacology, 10, 157-170, 1994.
10. Theodore, W. H., DiChiro, G., Margolin, R. et al., Barbiturates reduce human cerebral glucose metabolism, Neurology, 36, 60-64, 1986.
11. Foster, N. L., VanDerSpek, A. F. L., Aldrich, M. S. et al., The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography, J. Cereb. Blood Flow Metab., 7, 415-420, 1987.
12. Buchsbaum, M. S., Wu, J., Haier, R. et al., Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder, Life Sci., 40, 2393-2400, 1987.
13. de Wit, H., Metz, J. T., and Gatley, J., Relationship between mood and regional metabolism after a moderate dose of ethanol, J. Cereb. Blood Flow Metab., 9, S325-S325, 1989.
14. de Wit, H., Metz, J., Wagner, N. et al., Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET, Alcohol. Clin. Exp. Res., 14, 482-489, 1990.
15. Wolkin, A., Angrist, B., Wolf, A. et al., Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography, Psychopharmacology (Berl.), 92, 241-246, 1987.
16. Bartzokis, G., Beckson, M., Newton, T., Mandelkern, M., Brown, C., Mintz, J., Foster, J. A., Ling, W., and Bridge, P., Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria, Neuropsychopharmacology, 20, 582-590, 1999.
17. Pearlson, G. D., Jeffery, P. J., Harris, G. J. et al., Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects, Am. J. Psychiatry, 150, 495-497, 1993.
18. Gollub, R. L., Breiter, H. C., Kantor, H. et al., Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects, J. Cereb. Blood Flow Metab., 18, 724-734, 1998.
19. Breiter, H. C., Gollub, R. L., Weisskoff, R. M. et al., Acute effects of cocaine on human brain activity and emotion, Neuron, 19, 591-611, 1997.
20. Kuhar, M. J., Ritz, M. C., and Boja, J. W., The dopamine hypothesis of the reinforcing properties of cocaine, Trends Neurosci., 14, 299-302, 1991.
21. 123I]3β-(4-iodophenyl)tropan-2 β-carboxylic acid methyl ester (RTI-55), a unique cocaine receptor ligand for imaging the dopamine and serotonin transporters in vivo, Med. Chem. Res., 1, 289-294, 1991.
22. 123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts, Psychopharmacology (Berl.), 122, 358-362, 1995.
23. Volkow, N. D., Wang, G. J., Fowler, J. S. et al., Relationship between psychostimulant-induced "high" and dopamine transporter occupancy, Proc. Natl. Acad. Sci. U.S.A., 93, 10388-10392, 1996.
24. Volkow, N. D., Wang, G. J., Fischman, M. W. et al., Relationship between subjective effects of cocaine and dopamine transporter occupancy, Nature, 386, 827-833, 1997.
25. Volkow, N. D., Wang, G. J., Fowler, J. S. et al., Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high", J. Pharmacol. Exp. Ther., 288, 14-20, 1999.
26. 11C]raclopride at dopamine receptors in human subjects, Am. J. Psychiatry, 1997; 154, 1209-1213.
27. Brewer, C. and Mathew K., Naloxone and opiate addiction (letter), Lancet, 2, 683-684, 1989.
28. Gonzalez, J. and Brogden, R., Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence, Drugs, 35, 192-213, 1988.
29. Tiffany, C. W., Olkowski, J. L., Tays, K. L. et al., Characterization of drugs which descriminate between uptake and ligand binding sites at the dopamine tranporter protein, Soc. Neurosci. Abstr., 22, 369, 1996.
30. Fox, B. S., Kantak, K. M., Edwards, M. A. et al., Efficacy of a therapeutic cocaine vaccine in rodent models, Nat. Med., 2, 1129-1132, 1996.
31. Landry, D. W., Immunotherapy for cocaine addiction, Sci. Am., 276, 42-45, 1997.
32. Volkow, N. D., Mullani, N., Gould, K. L. et al., Cerebral blood flow in chronic cocaine users: a study with positron emission tomography, Br. J. Psychiatry, 152, 641-648, 1988.
33. Tumeh, S. S., Nagel, J. S., English, R. J. et al., Cerebral abnormalities in cocaine abusers: Demonstration by SPECT perfusion brain scintigraphy, Radiology, 176, 821-824, 1990.
34. Holman, B. L., Mendelson, J., Garada, B. et al., Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users, J. Nucl. Med., 34, 723-727, 1993.
35. Kosten, T. R., Pharmacotherapy of cerebral ischemia in cocaine dependence, Drug Alcohol Depend., 49, 133-144, 1998.
36. Levin, J. M., Mendelson, J. H., Holman, B. L. et al., Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine, J. Nucl. Med., 36, 1211-1215, 1995.
37. Baxter, L. R., Jr., Schwartz, J. M., Phelps, M. E. et al., Localization of neurochemical effects of cocaine and other stimulants in the human brain, J. Clin. Psychiatry, 49, 23-26, 1988.
38. Baxter, L. R., Jr., Phelps, M. E., Mazziotta, J. C. et al., Cerebral metabolic rates for glucose in mood disorders: Studies with positron emission tomography and fluorodeoxyglucose F 18, Arch. Gen. Psychiatry, 42, 441-447, 1985.
39. Volkow, N. D., Fowler, J. S., Wolf, A. P. et al., Changes in brain glucose metabolism in cocaine dependence and withdrawal, Am. J. Psychiatry, 148, 621-626, 1991.
40. Volkow, N. D., Hitzemann, R., Wang, G. J. et al., Long-term frontal brain metabolic changes in cocaine abusers, Synapse, 1992; 11, 184-190.
41. Stapleton, J. M., Morgan, M. J., Phillips, R. L. et al., Cerebral glucose utilization in polysubstance abuse, Neuropsychopharmacology, 13, 21-31, 1995.
42. Pilotte, N. S., Sharpe, L. G., Rountree, S. D. et al., Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens, Synapse, 22, 87-92, 1996.
43. Pilotte, N. S. and Sharpe, L. G., Cocaine withdrawal alters regulatory elements of dopamine neurons, NIDA. Res. Monogr., 163, 193-202, 1996.
44. Tsukada, H., Kreuter, J., Maggos, C. E. et al., Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography, J. Neurosci., 16, 7670-7677, 1996.
45. 11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats, Neuropsychopharmacology, 19, 146-153, 1998.
46. Claye, L. H., Akunne, H. C., Davis, M. D. et al., Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration, Mol. Neurobiol., 1995; 11, 55-66, 1995.
47. Farfel, G. M., Kleven, M. S., Woolverton, W. L. et al., Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey, Brain Res., 578, 235-243, 1992.
48. Volkow, N. D., Wang, G. J., Fowler, J. S. et al., Cocaine uptake is decreased in the brain of detoxified cocaine abusers, Neuropsychopharmacology, 14, 159-168, 1996.
49. Volkow, N. D., Fowler, J. S., Wang, G. J. et al., Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers, Synapse, 14, 169-177, 1993.
50. Wu, J. C., Bell, K., Najafi, A. et al., Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal, Neuropsychopharmacology, 17, 402-409, 1997.
51. Kuhar, M. J. and Pilotte, N. S., Neurochemical changes in cocaine withdrawal, Trends. Pharmacol. Sci., 17, 260-264, 1996.
52. Markou, A. and Koob, G. F., Postcocaine anhedonia: an animal model of cocaine withdrawal, Neuropsychopharmacology, 4, 17-26, 1991.
53. Zhu, M. Y., Juorio, A. V., Paterson, I. A. et al., Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors, Eur. J. Pharmacol., 238, 157-164, 1993.
54. Handelsman, L., Rosenblum, A., Palij, M. et al., Bromocriptine for cocaine dependence. A controlled clinical trial, Am. J. Addict., 6, 54-64, 1997.
55. Hubner, C. B. and Koob G. F., Bromocriptine produces decreases in cocaine self-administration in the rat, Neuropsychopharmacology, 3, 101-108, 1990.
56. Glowa, J. R., Fantegrossi, W. E., Lewis, D. B. et al., Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylproplyl)piperazinyl decanoate, a long-acting ester derivative of GBR 12909, J. Med. Chem., 39, 4689-4691, 1996.
57. Dewey, S. L., Morgan, A. E., Ashby, C. R., Jr. et al., A novel strategy for the treatment of cocaine addiction, Synapse, 30, 119-129, 1998.
58. Unterwald, E. M., Horne-King, J., and Kreek, M. J., Chronic cocaine alters brain mu opioid receptors, Brain Res., 584, 314-318, 1992.
59. Zubieta, J. K., Gorelick, D. A., Stauffer, R. et al., Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving, Nat. Med., 2, 1225-1229, 1996.
60. Mello, N. K., Mendelson, J. H., Bree, M. P. et al., Buprenorphine suppresses cocaine self-administration by rhesus monkeys, Science, 245, 859-862, 1989.
61. Mello, N. K., Mendelson, J. H., Lukas, S. E. et al., Buprenorphine treatment of opiate and cocaine abuse: Clinical and preclinical studies, Harv. Rev. Psychiatry, 1, 168-183, 1993.
62. Kosten, T. R., Rosen, M. I., Schottenfeld, R. et al., Buprenorphine for cocaine and opiate dependence, Psychopharmacol. Bull., 28, 15-19, 1992.
63. Grant, S., London, E. D., Newlin, D. B. et al., Activation of memory circuits during cue-elicited cocaine craving, Proc. Natl. Acad. Sci. U.S.A., 93, 12040-12045, 1996.
64. Buckner, R. L. and Tulving, E., Neuroimaging studies of memory: theory and recent PET results, in Handbook of Neuropsychology, Boller, F. and Grafman, J., Eds., Elsevier, Amsterdam, 1995, 439-466.
65. Fiez, J. A., Cerebellar contributions to cognition, Neuron, 16, 13-15, 1996.
66. Cahill, L., Haier, R. J., Fallon, J. et al., Amygdala activity at encoding correlated with long-term, free recall of emotional information, Proc. Natl. Acad. Sci. U.S.A., 93, 8016-8021, 1997.
67. Maas, L. C., Lukas, S. E., Kaufman, M. J. et al., Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving, Am. J. Psychiatry, 155, 124-126, 1998.
68. Childress, A. R., Mozley, P. D., McElgin, W. et al., Limbic activation during cue-induced cocaine craving, Am. J. Psychiatry, 156, 11-18, 1999.
69. Cascella, N. G., Pearlson, G., Wong, D. F. et al., Effects of substance abuse on ventricular and sulcal measures assessed by computerised tomography, Br. J. Psychiatry, 159, 217-221, 1991.
70. Morgan, M. J., Cascella, N. G., Stapleton, J. M. et al., Sensitivity to subjective effects of cocaine in drug abusers: Relationship to cerebral ventricular size, Am. J. Psychiatry, 150, 1712-1717, 1993.
71. Liu, X., Phillips, R. L., Resnick, S. M. et al., No evidence of ventriculomegaly in polydrug abusers: A volumetric magnetic resonance imaging study, Acta Neurol. Scand., 92, 83-90, 1995.
72. Liu, X., Vaupel, D. B., Grant, S. et al., Effect of cocaine-related environmental stimuli on the spontaneous electroencephalogram in polydrug abusers, Neuropsychopharmacology, 19, 10-17, 1998.
73. Wagner, H. N., Jr., Burns, H. D., Dannals, R. F. et al., Imaging dopamine receptors in the human brain by positron tomography, Science, 221, 1264-1266, 1983.
74. Wong, D. F., Wagner, H. N., Jr., Dannals, R. F. et al., Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain, Science, 226, 1393-1396, 1984.